Edward Cha

3.5k citations
56 papers · 1.8k · 1 hit paper · h-index 21

Impact in

  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
    • Cytokine Signaling Pathways and Interactions
    • Colorectal Cancer Treatments and Studies
  • Immunology top 5%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • interferon and immune responses

Papers in

    • Cancer Immunotherapy and Biomarkers 31
    • Colorectal Cancer Treatments and Studies 9
    • CAR-T cell therapy research 8
    • Immunotherapy and Immune Responses 11

Edward Cha

55 papers receiving 1.8k citations

Edward Cha's Hit Papers

Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b–2, study 2025 · 32 citations
320Years since publication102030

Peers

Edward Cha
Comparison fields: 5 of 75
  • Oncology 1.2k
  • Immunology 748
  • Cancer Research 143
  • Hepatology 70
  • Pathology and Forensic Medicine 136
Replace Jesse M. Zaretsky with:
Jesse M. Zaretsky United States
Malin S. Nilsson Sweden
Davis Y. Torrejon United States
Simon J. Dovedi United Kingdom
Justin D. Saco United States
Diwakar Davar United States
Julian A. Marin‐Acevedo United States
Alex Chehrazi‐Raffle United States
Kim C. Ohaegbulam United States
Maria Libera Ascierto United States
Edward Cha relative to Jesse M. Zaretsky United States Jesse M. Zaretsky's profile →
Citations per field
00.5×5.5×
Jesse M. Zaretsky · 1×
Citations per year

Countries citing papers authored by Edward Cha

Since Specialization
Citations

This map shows the geographic impact of Edward Cha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Cha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Cha more than expected).

Fields of papers citing papers by Edward Cha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward Cha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Cha. The network helps show where Edward Cha may publish in the future.

Co-authors

The 25 scholars most cited alongside Edward Cha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Edward Cha Line = papers co-authored together Edward Cha links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2000325
2 2014299
3 2019180
4 2016131
5 200854
6 202447
7 202345
8 201744
9 201243
10 201542
11 201141
12 201637
13 201837
14 201236
15 202034
16
Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b–2, study
Hit paper breakdown →
202532
17 201529
18 201528
19 201627
20 202326

About Edward Cha

Edward Cha is a scholar working on Oncology, Immunology, Pulmonary and Respiratory Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 56 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (31 papers), Immunotherapy and Immune Responses (11 papers), Colorectal Cancer Treatments and Studies (9 papers), CAR-T cell therapy research (8 papers), Advanced Breast Cancer Therapies (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Melanoma and MAPK Pathways (5 papers) and Prostate Cancer Treatment and Research (4 papers). The work is most often cited by research in Oncology (1.2k citations), Immunology (748 citations), Cancer Research (143 citations), Hepatology (70 citations) and Pathology and Forensic Medicine (136 citations). Edward Cha has collaborated with scholars based in United States, South Korea and United Kingdom. Frequent co-authors include Lawrence Fong, Christian Schindler, Christopher Y. Park, Malek Faham, Mark Klinger, Craig Cummings, Antoni Ribas, Yafei Hou, Jeffrey J. Wallin and Jeffrey R. Infante. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, The Lancet Oncology and ESMO Open.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact